|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 45/06 | |||
| A61P 35/00 | |||
| C07K 14/47 | |||
| C07K 16/26 | |||
| C07K 16/18 | |||
| C07K 16/28 | |||
| C07K 16/30 | |||
| A61K 38/00 | |||
| A61K 39/00 | |||
| A61P 35/02 | |||
| A61P 37/04 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3377103 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16867215.2 |
| Europos patento paraiškos padavimo data | 2016-11-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/062748 |
| Data | 2016-11-18 |
| (87) | Numeris | WO 2017/087789 |
| Data | 2017-05-26 |
| (30) | Numeris | Data | Šalis |
| 201562257552 P | 2015-11-19 | US | |
| 201562270907 P | 2015-12-22 | US |
| (72) |
COBBOLD, Mark, US
|
| (73) |
Revitope Limited,
Angel Building 407 St. John Street, London EC1V 4AD,
GB
|
| (54) | FUNCTIONAL ANTIBODY FRAGMENT COMPLEMENTATION FOR A TWO-COMPONENTS SYSTEM FOR REDIRECTED KILLING OF UNWANTED CELLS |
| FUNCTIONAL ANTIBODY FRAGMENT COMPLEMENTATION FOR A TWO-COMPONENTS SYSTEM FOR REDIRECTED KILLING OF UNWANTED CELLS |